April McClain Delaney is spending her family money to take a House seat, which is one way to get to Congress. She's self-funded over $8 million into her primary campaign against David Trone, dropped $825,000 in a single week, and is now the subject of a Baltimore Sun fact-check on whether her ads are telling the truth about either candidate. The race is close, one recent poll has Trone at 43 percent and Delaney at 40, and her opponents' supporters on social media are arguing she's been misrepresenting her own voting record while hitting Trone. That's the political story. The financial story, sitting in her public disclosures, is that the same woman running attack ads about trustworthiness has filed 31 stock trades in the last 90 days. Blind Trust has them all.
The Ad War and the Voting Record
The Baltimore Sun piece is worth reading for what it says about how this primary is being fought. Both candidates are running ads. Both ads are being fact-checked. That's the nature of a close intra-party race between two wealthy candidates in a district that has watched a lot of campaign money get lit on fire in recent cycles.
The social chatter is sharper. Delaney's critics are pushing a specific line: that she's a centrist who has voted with Republicans on multiple occasions while running ads that suggest otherwise. Delaney's campaign, predictably, disagrees. The Baltimore Sun is doing the work of sorting the claims out.
What nobody in the ad war is talking about: the disclosures.
31 Trades in 90 Days
Most sitting members file a handful of trades per quarter. Delaney filed 31 in the last 90 days alone. That's not extraordinary for the busiest traders in Congress, but it's not the portfolio of someone who handed everything to a blind trust and forgot about it either.
The recent moves are spread across a range of sectors with no obvious single thesis. On April 30 alone, she filed five separate trades: sales of Morningstar (MORN), Clean Harbors (CLH), and Service Corporation International (SCI), and purchases of STERIS (STE) and Markel Group (MKL). The day before, April 29, she bought Packaging Corporation of America (PKG) and TransDigm Group (TDG). She bought PKG again on April 24, the same day she sold Fortune Brands Innovations (FBIN) and C.H. Robinson Worldwide (CHRW) and bought Nasdaq Inc. (NDAQ).
All of these are in the $1,000-$15,000 range per trade, except the CHRW sale, which clocked in at $15,000-$50,000. Not retirement-account-rattling money on its own. But 31 trades in a quarter is a pace, not a coincidence.
Her full disclosure record is on Blind Trust.
The Alpha Record: Honest Version
Here's where it gets interesting in the least flattering way possible.
Blind Trust scores each trade against the S&P 500 over the following 30 days. Delaney's full scored sample is 120 trades. Of those, 44 were positive. Seventy-six were negative. Her mean 30-day alpha across the full sample is negative 2.4 percent.
The math: she's underperformed the market on 63 percent of her scored trades.
She has bright spots. A March 31 purchase of Entegris (ENTG) returned 20.2 percent alpha in 30 days. A February 4 buy of EMCOR Group (EME) returned 13.3 percent. A February 19 sale of Morningstar came in at plus 11.9 percent alpha.
She also has the other kind. A April 8 sale of Benchmark Electronics (TECH) came in at negative 22.7 percent alpha. A February 24 sale of Fortune Brands Innovations hit negative 24.9 percent. And her January 15 sale of Morningstar, the same ticker she sold again in February and again in April, came in at negative 27.0 percent alpha. She has sold Morningstar at least three times in this sample. The first time cost her on a relative basis.
None of these trades carry a committee overlap flag. Delaney sits on the House Committee on Agriculture and the House Committee on Science, Space, and Technology. Her disclosed holdings are in financial services companies, packaging firms, defense contractors, and specialty insurers. The Venn diagram between her committee assignments and her portfolio is two circles that don't touch. That means there's no oversight angle on any of these specific positions. It's just a portfolio that's losing to the index.
The Banking Votes and the Nasdaq Buy
On May 20, Delaney voted Yea on four pieces of legislation that cleared the House floor. Two of them are worth naming: the American Access to Banking Act (H.R. 4544) and the Community Bank Deposit Access Act of 2025 (H.R. 5317), both of which passed. She also voted Yea on the Keeping Deposits Local Act (H.R. 3234).
Three banking bills in one day. She also bought Nasdaq Inc. On April 24, which owns exchange infrastructure and financial market technology. Nasdaq is not a bank, and banking legislation is not in her committee remit, she's on Agriculture and Science, not Financial Services. A floor vote on a banking bill is just a floor vote.
Still: the calendar has her buying a financial market infrastructure stock in late April and voting on three bank-related bills in late May. No flagged overlap in the data. The timing is what it is. Readers get to bring their own opinion.
What the Self-Funding Tells You
The $8 million self-fund number is the political story, but it's also the financial context. Delaney comes from serious money. Her husband John Delaney is a former congressman and ex-presidential candidate who made a fortune in commercial lending. This is not a middle-class member stretching to cover campaign costs. The portfolio activity in these disclosures is a rounding error against the campaign spend.
Which cuts both ways. If you're already this wealthy, you're not trading a brokerage account of $1K-$15K positions for the upside. The 31 trades in 90 days are either a managed account on autopilot or something more attentive. Either way, the performance record suggests the autopilot is not set correctly. Negative 2.4 percent mean alpha across 120 scored trades is a data point, not a narrative. But it's a data point.
The Votes She Took the Other Way
The social criticism about Delaney voting with Republicans gets some texture from the roll call. She voted Nay on the Veterans 2nd Amendment Protection Act (H.R. 1041) on May 21, which passed anyway, and Nay on the Sharri Briley and Eric Edmundson Veterans Benefits Expansion Act (H.R. 6047) on the same day, which also passed. She voted Nay on the FISA extension bill (H.R. 9238) on June 11, which failed.
Whether those votes make her a centrist or a progressive is an argument her primary opponents are spending eight figures to have. Blind Trust doesn't score ideology. We score the disclosures.
The Portrait
What the filings show is a sitting member who is extremely active in her personal brokerage account, underperforming the market on nearly two-thirds of scored trades, holding no positions that overlap with her committee assignments, and currently under a fact-check microscope in the middle of a primary she's trying to buy with her own money.
Members are required to disclose. They are not required to divest, recuse, abstain, blush, or look up from their phones.
The ads are about Delaney's record. The disclosures are also about her record. The Baltimore Sun is handling the ads. Blind Trust is handling the rest.